Trexquant Investment LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,533,351
+27.5%
21,267
+30.1%
0.04%
+21.2%
Q1 2023$1,202,780
-23.5%
16,351
-30.5%
0.03%
-26.7%
Q4 2022$1,571,737
+16.0%
23,529
+49.5%
0.04%
-6.2%
Q3 2022$1,355,000
+224.9%
15,734
+236.6%
0.05%
+152.6%
Q2 2022$417,000
-26.6%
4,674
+27.0%
0.02%
-45.7%
Q4 2021$568,000
-9.8%
3,680
-44.3%
0.04%
-14.6%
Q3 2020$630,000
+2.4%
6,611
+20.2%
0.04%
-4.7%
Q2 2020$615,000
-30.7%
5,502
-54.9%
0.04%
-32.8%
Q1 2020$888,000
+168.3%
12,205
+267.2%
0.06%
+120.7%
Q3 2019$331,000
-29.4%
3,324
-19.0%
0.03%
-31.0%
Q2 2019$469,000
-87.2%
4,106
-84.8%
0.04%
-81.7%
Q4 2018$3,662,000
+131.0%
26,987
+367.5%
0.23%
+92.4%
Q3 2018$1,585,000
+189.8%
5,773
-18.7%
0.12%
+112.5%
Q1 2015$547,000
-0.9%
7,100
-31.7%
0.06%
-42.9%
Q4 2014$552,00010,3920.10%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders